We are live on ! Find out more
ALT icon

Altimmune
ALT

37 hedge funds and large institutions have $37M invested in Altimmune in 2013 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,140,300% more call options, than puts

Call options by funds: $21.4M | Put options by funds: $1K

0% more funds holding

Funds holding: 37 → 37 (0)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

0% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 9

7% less capital invested

Capital invested by funds: $39.9M → $37M (-$2.92M)

Holders
37
Holders Change
–
Holders Change %
0%
% of All Funds
1.07%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
5
Increased
9
Reduced
9
Closed
5
Calls
$21.4M
Puts
$1K
Net Calls
+$21.4M
Net Calls Change
+$15.5M

Top Buyers

1
JCI
Jet Capital Investors
New York
+$421K
2
SC
Sophrosyne Capital
New York
+$386K
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$220K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$97.9K
5
U
UBS
Switzerland
+$89.5K

Top Sellers

1
Deutsche Bank
Deutsche Bank
Germany
-$280K
2
Renaissance Technologies
Renaissance Technologies
New York
-$211K
3
PCM
Perkins Capital Management
Minnesota
-$70.4K
4
FCH
Freestone Capital Holdings
Washington
-$56K
5
VKH
Virtu KCG Holdings
New York
-$51K
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
26
State Street
Massachusetts
$35K – – –
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
$29K -$10.1K -17 -25%
RCM
28
Rotella Capital Management
Washington
$19K -$16.7K -28 -45%
Citigroup
29
Citigroup
New York
$8K -$1.79K -3 -18%
US Bancorp
30
US Bancorp
Minnesota
$4K – – –
TRCT
31
Tower Research Capital (TRC)
New York
$4K +$2.98K +5 +250%
AllianceBernstein
32
AllianceBernstein
Tennessee
$2K – – –
Royal Bank of Canada
33
Royal Bank of Canada
Ontario, Canada
$2K – – –
BNP Paribas Financial Markets
34
BNP Paribas Financial Markets
France
$1.72K +$1.79K +3 New
GC
35
Globeflex Capital
California
$1K – – –
AIG
36
American International Group
New York
$558 -$1.79K -3 -75%
Manulife (Manufacturers Life Insurance)
37
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$5 – – –
Deutsche Bank
38
Deutsche Bank
Germany
– -$280K -445 Closed
FCH
39
Freestone Capital Holdings
Washington
– -$56K -158 Closed
VKH
40
Virtu KCG Holdings
New York
– -$51K -81 Closed
OC
41
Oppenheimer & Co
New York
– -$21K -33 Closed
Wells Fargo
42
Wells Fargo
California
– -$2K -3 Closed
1
2

ALT Hedge Fund Activity: Q4 2013 in Review

37 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q4 2013, worth a combined $37M — down 7.3% from $39.9M a quarter earlier.

Fund positioning in ALT was balanced in Q4 2013: 5 funds opened new positions, 5 closed out, 9 added to existing stakes and 9 trimmed.

The largest buyer was Jet Capital Investors, adding an estimated $421K. The largest seller was Deutsche Bank, exiting entirely with an estimated $280K sold.

  • 37 institutional investors held Altimmune (ALT) as of Q4 2013, unchanged from Q3 2013.
  • Funds reported $37M of Altimmune stock for Q4 2013, down 7.3% quarter-over-quarter.
  • 5 funds opened new Altimmune positions in Q4 2013 and 5 closed out, a net change of 0 holders.
  • The largest Altimmune buyer in Q4 2013 was Jet Capital Investors, an estimated $421K added.
  • The largest Altimmune seller in Q4 2013 was Deutsche Bank, an estimated $280K sold.

Based on aggregated 13F filings for Q4 2013.